top of page
INVEST ON US
INTRA-KER is raising capital to drive project development and position the company for long-term growth. With a clear roadmap and access to a rapidly expanding global ophthalmology market, INTRA-KER offers investors a unique opportunity to participate in advancing transformative solutions with strong commercial potential.
First Round Structure
INTRA-KER is registered in Italy as innovative startup.
Funds allocation will be split mainly in R&D of clinical trial and startup initial costs.
G&A
5%
HR
5%
MARKETING
5%
R&D
CLINICAL TRIAL
85%
1.5 Million €
Funding
Get in Touch
For inquiries or assistance, please feel free to reach out to our Investor Relations team. We are here to help you with any questions you may have.
bottom of page